The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictors of erlotinib utilization and the impact of erlotinib use on overall survival in advanced, non-small cell lung cancer.
 
Jennifer L. Ersek
No Relationships to Disclose
 
James Thomas Symanowski
Consulting or Advisory Role - Boston Biomedical; Endocyte (Inst); immatics; Lilly; Ra Pharma (Inst)
Research Funding - Bayer (Inst); Celgene (Inst); Novocure (Inst)
 
Edward S. Kim
Honoraria - AstraZeneca; Boehringer Ingelheim; Celgene; Lilly
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Lilly
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Celgene; Lilly
 
Swann Arp Adams
No Relationships to Disclose
 
James R. Hébert
No Relationships to Disclose
 
Jan Marie Eberth
No Relationships to Disclose